Page last updated: 2024-08-23

mefloquine and exudates

mefloquine has been researched along with exudates in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19902 (28.57)18.7374
1990's1 (14.29)18.2507
2000's0 (0.00)29.6817
2010's4 (57.14)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Davis, DR; Lambros, C; Lewis, GE1
Ho, KB; Mak, JW; Ramadas, M1
Ang, HH; Chan, KL; Mak, JW1
Chin, LC; Fong, MY; Lau, YL; Noraishah, MA; Rohela, M; Tan, LH1
Hashimoto, A; Hayakawa, K; Iwagami, M; Kanagawa, S; Kano, S; Kato, Y; Kutsuna, S; Ohmagari, N; Takeshita, N; Tanizaki, R; Ujiie, M1
Anstey, NM; Barber, BE; Dhanaraj, P; Grigg, MJ; Menon, J; Price, RN; Rajahram, G; von Seidlein, L; William, T; Yeo, TW1
Anstey, NM; Barber, BE; Dhanaraj, P; Grigg, MJ; McCarthy, JS; Menon, J; Pasay, C; Price, RN; Rajahram, GS; von Seidlein, L; Wilkes, CS; William, T; Yeo, TW1

Trials

2 trial(s) available for mefloquine and exudates

ArticleYear
A study protocol for a randomised open-label clinical trial of artesunate-mefloquine versus chloroquine in patients with non-severe Plasmodium knowlesi malaria in Sabah, Malaysia (ACT KNOW trial).
    BMJ open, 2014, Aug-19, Volume: 4, Issue:8

    Topics: Antimalarials; Artemisinins; Artesunate; Chloroquine; Female; Humans; Malaria; Malaysia; Male; Mefloquine; Plasmodium knowlesi; Research Design; Severity of Illness Index

2014
Artesunate-mefloquine versus chloroquine for treatment of uncomplicated Plasmodium knowlesi malaria in Malaysia (ACT KNOW): an open-label, randomised controlled trial.
    The Lancet. Infectious diseases, 2016, Volume: 16, Issue:2

    Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Chloroquine; Drug Therapy, Combination; Female; Humans; Malaria; Malaysia; Male; Mefloquine; Middle Aged; Plasmodium knowlesi; Young Adult

2016

Other Studies

5 other study(ies) available for mefloquine and exudates

ArticleYear
Antimalarial drug susceptibility of Plasmodium falciparum isolates from forest fringe dwelling aborigines (Orang Asli) of Peninsular Malaysia.
    The American journal of tropical medicine and hygiene, 1989, Volume: 41, Issue:1

    Topics: Animals; Antimalarials; Child; Chloroquine; Drug Resistance; Humans; Malaria; Malaysia; Mefloquine; Plasmodium falciparum; Quinolines

1989
A study of the sensitivity of Plasmodium falciparum to chloroquine and mefloquine using the in vitro microtechnique in Peninsular Malaysia.
    Transactions of the Royal Society of Tropical Medicine and Hygiene, 1987, Volume: 81, Issue:2

    Topics: Antimalarials; Chloroquine; Drug Resistance; Humans; Malaria; Malaysia; Mefloquine; Parasitology; Plasmodium falciparum; Quinolines

1987
In vitro susceptibility studies of Malaysian Plasmodium falciparum isolates and clones against schizontocidal drugs.
    Folia parasitologica, 1998, Volume: 45, Issue:3

    Topics: Animals; Antimalarials; Chloroquine; Malaysia; Mefloquine; Plasmodium falciparum; Quinine

1998
Plasmodium knowlesi reinfection in human.
    Emerging infectious diseases, 2011, Volume: 17, Issue:7

    Topics: Adult; Antimalarials; Artemether; Artemisinins; Blood Transfusion; Doxycycline; Ethanolamines; Fluorenes; Hemolysis; Humans; Lumefantrine; Malaria; Malaysia; Male; Mefloquine; Microscopy; Phylogeny; Plasmodium knowlesi; Polymerase Chain Reaction; Protozoan Proteins; Quinine; Recurrence

2011
First case of Plasmodium knowlesi infection in a Japanese traveller returning from Malaysia.
    Malaria journal, 2013, Apr-15, Volume: 12

    Topics: Adult; Antimalarials; Asian People; DNA, Protozoan; Humans; Malaria; Malaysia; Male; Mefloquine; Plasmodium knowlesi; Polymerase Chain Reaction; Sequence Analysis, DNA; Tokyo; Travel; Treatment Outcome

2013